Joseph C Grippo DeceasedRochester, NY

Joseph Grippo Phones & Addresses

Rochester, NY

Brooklyn, NY

Bowie, MD

Mentions for Joseph C Grippo

Joseph Grippo resumes & CV records

Resumes

Joseph Grippo Photo 33

Joseph Grippo

Joseph Grippo Photo 34

Joseph Grippo

Joseph Grippo Photo 35

Joseph Grippo

Joseph Grippo Photo 36

Director - Baseball Assistance Team At Major League Baseball

Location:
Greater New York City Area
Industry:
Sports
Joseph Grippo Photo 37

Executive Director - Baseball Assistance Team

Location:
Greater New York City Area
Industry:
Sports
Joseph Grippo Photo 38

Joseph Grippo

Location:
United States
Joseph Grippo Photo 39

Joseph Grippo

Location:
United States
Joseph Grippo Photo 40

Executive Director At Baseball Assistance Team

Location:
United States
Industry:
Nonprofit Organization Management

Publications & IP owners

Us Patents

Urea Derivatives

US Patent:
6528543, Mar 4, 2003
Filed:
Mar 21, 2000
Appl. No.:
09/532506
Inventors:
Fred Thomas Bizzarro - Colonia NJ
Wendy Lea Corbett - Randolph NJ
Antonio Focella - Wayne NJ
Joseph Francis Grippo - Stirling NJ
Nancy-Ellen Haynes - Cranford NJ
George William Holland - North Caldwell NJ
Robert Francis Kester - Hackensack NJ
Paige Erin Mahaney - Montclair NJ
Ramakanth Sarabu - Cedar Grove NJ
Assignee:
Hoffman-La Roche Inc. - Nutley NJ
International Classification:
A61K 3117
US Classification:
514594, 514522, 514530, 514542, 514595, 558413, 558417, 560 9, 560 13, 564 47, 564 56
Abstract:
Glucokinase activating compounds of the formula wherein R and R are independently hydrogen, halo, amino, nitro, cyano, sulfonamido, lower alkyl, perfluoro-lower alkyl, lower alkyl thio, perfluoro-lower alkyl thio, lower alkyl sulfonyl, or perfluoro-lower alkyl sulfonyl; R is cycloalkyl having from 3 to 7 carbon atoms or lower alkyl having from 2 to 4 carbon atoms; R is hydrogen, lower alkyl, lower alkenyl, hydroxy lower alkyl, halo lower alkyl, R and R are hydrogen or lower alkyl; and n is 0, 1, 2, 3 or 4; or a pharmaceutically acceptable salt thereof.

Heteroaromatic Glucokinase Activators

US Patent:
6610846, Aug 26, 2003
Filed:
Sep 28, 2000
Appl. No.:
09/675781
Inventors:
Fred Thomas Bizzarro - Colonia NJ
Wendy Lea Corbett - Randolph NJ
Joseph Francis Grippo - Stirling NJ
Nancy-Ellen Haynes - Cranford NJ
George William Holland - Houston TX
Robert Francis Kester - Verona NJ
Paige Erin Mahaney - Montclair NJ
Ramakanth Sarabu - Pine Brook NJ
Assignee:
Hoffman-La Roche Inc. - Nutley NJ
International Classification:
C07D23724
US Classification:
544182, 544211, 544224, 544238, 544329, 544336
Abstract:
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 3-position being a substituted phenyl group and at the 2-position being a methyl cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.

Heteroaromatic Glucokinase Activators

US Patent:
6951945, Oct 4, 2005
Filed:
Jul 9, 2003
Appl. No.:
10/616359
Inventors:
Fred Thomas Bizzarro - Colonia NJ, US
Wendy Lea Corbett - Randolph NJ, US
Joseph Francis Grippo - Stirling NJ, US
Nancy-Ellen Haynes - Cranford NJ, US
George William Holland - Houston TX, US
Robert Francis Kester - Verona NJ, US
Paige Erin Mahaney - Montclair NJ, US
Ramakanth Sarabu - Pine Brook NJ, US
Assignee:
Hoffman-La Roche Inc. - Nutley NJ
International Classification:
C07D285/06
C07D285/12
C07D277/04
C07D275/02
US Classification:
548127, 548128, 548134, 548139, 548195, 548214
Abstract:
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 3-position being a substituted phenyl group and at the 2-position being a methyl cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.

Heteroaromatic Glucokinase Activators

US Patent:
7223868, May 29, 2007
Filed:
Apr 4, 2005
Appl. No.:
11/098717
Inventors:
Fred Thomas Bizzarro - Colonia NJ, US
Wendy Lea Corbett - Randolph NJ, US
Joseph Francis Grippo - Stirling NJ, US
Nancy-Ellen Haynes - Cranford NJ, US
George William Holland - Houston TX, US
Robert Francis Kester - Verona NJ, US
Paige Erin Mahaney - Montclair NJ, US
Ramakanth Sarabu - Pine Brook NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
C07D 213/75
C07D 213/84
US Classification:
546289, 546297, 546309, 546310
Abstract:
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 3-position being a substituted phenyl group and at the 2-position being a methyl cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.

Heteroaromatic Glucokinase Activators

US Patent:
2007020, Aug 30, 2007
Filed:
Apr 23, 2007
Appl. No.:
11/789105
Inventors:
Fred Bizzarro - Colonia NJ, US
Wendy Corbett - Randolph NJ, US
Joseph Grippo - Stirling NJ, US
Nancy-Ellen Haynes - Cranford NJ, US
George Holland - Houston TX, US
Robert Kester - Verona NJ, US
Paige Mahaney - Montclair NJ, US
Ramakanth Sarabu - Pine Brook NJ, US
International Classification:
A61K 31/425
C07C 211/00
C07C 211/01
C07C 311/00
C07D 277/00
US Classification:
514365000, 548199000, 562837000, 564001000, 564366000
Abstract:
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 3-position being a substituted phenyl group and at the 2-position being a methyl cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.

Heteroaromatic Glucokinase Activators

US Patent:
6320050, Nov 20, 2001
Filed:
Mar 15, 2000
Appl. No.:
9/526143
Inventors:
Fred Thomas Bizzarro - Colonia NJ
Wendy Lea Corbett - Randolph NJ
Joseph Francis Grippo - Stirling NJ
Nancy-Ellen Haynes - Cranford NJ
George William Holland - North Caldwell NJ
Robert Francis Kester - Hackensack NJ
Ramakanth Sarabu - Cedar Grove NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
C07D27738
C07D21326
C07D23942
US Classification:
544332
Abstract:
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.